Anzeige
Mehr »
Mittwoch, 11.02.2026 - Börsentäglich über 12.000 News
Drohnen, Robotik, E-Autos: Diese Hightech-Aktie könnte jetzt zünden
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
962 Leser
Artikel bewerten:
(2)

Beiersdorf AG: Extraordinary protection: NIVEA develops unique cosmetic sunscreen for a young girl

  • Thanks to NIVEA's specially developed cosmetic sunscreen, "Shadow Jumper" Charlotte enjoys short trips in the sun.
  • Four-year-old Charlotte suffers from a condition known as EPP - erythropoietic protoporphyria. People affected by this disease are often nicknamed "Shadow Jumpers," as they cannot be exposed to sunlight.
  • This unique R&D project is a strong proof point of how NIVEA delivers on the Beiersdorf purpose CARE BEYOND SKIN.

HAMBURG, Germany , Jan. 16, 2023 /PRNewswire/ -- The research and development department of Beiersdorf, the skin care company behind the NIVEA brand, has used its profound knowledge of the skin and research expertise to tailor a unique cosmetic sun protection product, specially made for a girl named Charlotte with a rare light disease called EPP. Research results on visible, high-energy light showed that special light-scattering pigments need to be added to the cosmetic sunscreen for Charlotte. This can prevent the light from penetrating the skin, allowing the girl to be exposed to sunlight for a short period of time - allowing her to enjoy a better quality of life.

NIVEA develops unique cosmetic sunscreen for a young girl

Charlotte, a four-year-old girl living near Münster, Germany, was born with the very rare genetic light disorder EPP. When her skin comes into direct contact with the visible, colored components of sunlight, a genetic defect causes neuropathic pain and triggers burns on the skin. Even as a baby, Charlotte suffered and cried out when the sunlight touched her skin, which is why her parents did everything they could to find help. When they reached out to NIVEA and Dr. Ludger Kolbe, a research project was launched for an innovative cosmetic sunscreen to help Charlotte.

The research was led by Dr. Ludger Kolbe, Chief Scientist for Photobiology at Beiersdorf and his team. Thanks to their expertise, they were able to develop a unique cosmetic sunscreen exclusively tailored to Charlotte. Dr. Kolbe explains: "With the high standards of skin protection that we at NIVEA pursue, we are delighted that we were able to find a special solution for Charlotte. With her personal sunscreen, she still has to be careful in the sun, but can spend a little longer playing outside with her friends."

The cosmetic sunscreen has changed the family's life. Applied thickly, the protective function allows the child to stay in direct sunlight for a short while - which was previously unthinkable. For Charlotte's parents, this means an immense relief in everyday life: "The NIVEA brand and the Beiersdorf Research and Development did everything possible to find a solution for Charlotte. When we saw Charlotte laughing in the sun after applying the cream for the first time, we were overwhelmed," says Johannes Hesseling, Charlotte's father.

The biological effects in sensitive and EPP skin are different which leads to the need of different care. This cosmetic sunscreen was especially developed for Charlotte and her individual skin needs, and thus is not part of our product portfolio or for sale. The product cannot cure EPP and Charlotte still needs to be very careful when in the sun, but it does give her a little more freedom when she steps outside. In the summer of 2021, the product was ready to be used by Charlotte for the first time.

When the sun becomes a challenge

For EPP patients, UV (the blue light from sunlight) causes severe pain, so they consistently seek shade whenever they are outside. This is exactly why the disease was unofficially coined as "shadow jumping" by the psychologist Elisabeth Anna Rufener[1]. Shadow jumping disease is caused by a rare genetic defect: When exposed to sunlight, a precursor of the red blood pigment, protoporphyrin, is deposited in the blood vessels. This ensures that energy from visible light is absorbed and triggers a chemical reaction - a burn in the vessels, which the affected patient perceives as severe pain and appears as burns on the skin[2].

More information about Charlotte's Cream: http://www.nivea.com/shadowjumper.
Additional information can also be found at https://www.beiersdorf.com/newsroom/press-releases/all-press-releases/2023/01/16-nivea-develops-unique-cosmetic-sunscreen-for-a-young-girl.

1. Source: EPP-Deutschland, Selbsthilfe EPP e.V. (2022/13/04) "Wenn Sonne weh tut" [online available on: http://www.epp-deutschland.de].
2. Source: vfa: Die forschenden Pharma-Unternehmen (2022/10/10) "Selbsthilfe EPP e.V. - Patienten mit erythropoetische Protoporphyrie" [online available on: https://www.vfa.de/de/patienten/patientenselbsthilfegruppen/psg-vorstellung-169.html].

Photo - https://mma.prnewswire.com/media/1983211/NIVEA_Cosmetic_Sunscreen.jpg
Logo - https://mma.prnewswire.com/media/1983212/NIVEA_Logo.jpg

NIVEA Logo

Cision View original content:https://www.prnewswire.co.uk/news-releases/extraordinary-protection-nivea-develops-unique-cosmetic-sunscreen-for-a-young-girl-301722217.html

© 2023 PR Newswire
Favoritenwechsel
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.